Navigation Links
Forte Research Systems Opens Their OnCore Software Developer Toolkit for Use With Any eIRB System
Date:6/29/2011

MADISON, Wis., June 29, 2011 /PRNewswire/ --

  • OnCore® Software Developer Toolkit (SDK) for eIRB integration now freely available.
  • Toolkit works with any eIRB system, including commercial and homegrown systems.
  • SDK model allows data to flow in either direction between Clinical Trials Management System (CTMS) and eIRB system.
  • Benefits include reduced manual data entry and more timely access to both clinical and regulatory data.

After proving the success of their electronic Institutional Review Board (eIRB) management system integration interface, Forte Research Systems, Inc. is making their Software Developers' Toolkit (SDK) freely available to all interested parties. The integrations were accomplished between Forte Research's market-leading product, the OnCore Clinical Research Management system, and various eIRB systems.

(Logo:  http://photos.prnewswire.com/prnh/20101115/CG02078LOGO)

"As the market leader, we feel this was the right thing to do for our customers, not to mention the clinical research community as a whole," said Srini Kalluri, Founder, President, CEO and Chief Customer Experience Officer at Forte Research Systems. "There's no reason for every one of our customers to have to reinvent the wheel when they want to share data between their eIRB system and OnCore."

The organizations that have implemented the OnCore SDK to exchange data with their eIRB systems cite similar motivations for pursuing this method for systems integration. Goals include reducing the amount of manual data entry, reducing errors by creating a single point of data entry, improving efficiency, supporting more streamlined processes, and increasing the availability of information to the people who need it. Additionally, the SDK model allows data to be inserted into the OnCore database as easily as it may be extracted.

Two NCI-designated Cancer Centers have completed their integration between OnCore and their eIRB systems using the SDK. At the Huntsman Cancer Institute (HCI) in Salt Lake City, Utah, the integration was with their implementation of Click Commerce's eResearch Portal. The other completed implementation is at the University of Virginia Cancer Center, which integrated OnCore with their homegrown eIRB system.

Reducing duplicative data entry and making processes more efficient were the primary goals for the Lineberger Comprehensive Cancer Center at the University of North Carolina in Chapel Hill, as well. Their ongoing implementation of the OnCore SDK is focused on cross-populating data between OnCore and a homegrown eIRB system. This information is related to Scientific Review Committee and IRB activities. In addition to review data, information related to protocol staff, protocol sponsors, and general protocol information is an ultimate goal of this data exchange.

"When we get that data to cross-populate between the two systems and we can activate studies more efficiently, that will be a great outcome," said Mary O'Dwyer, Clinical Protocol Office Associate Director at Lineberger.

Currently, there are several vendors in the marketplace who are successfully addressing the needs of IRBs with computerized systems. The OnCore SDK is general purpose and works with any commercial or homegrown system.

"The SDK model for integration has several advantages over a single-purpose interface," said Tony O'Hare, PhD, Co-founder, Vice President of Engineering, and Chief Collaboration Officer at Forte Research Systems. "Perhaps the most important benefit is that the result is available to every OnCore customer regardless of which eIRB system is in place at their institution."

Like all of Forte Research's major development initiatives, the new SDK was developed as part of a collaborative project in which members of the OnCore community worked closely with the company and provided operational expertise throughout the development process.

The "build-it-once" development model that Forte Research implemented for this SDK is the same model the company has taken from the beginning when first developing the OnCore system 11 years ago.

"What we did for CTMS, we are bringing to clinical research systems integration. Our goal is to minimize the cost of services for our customers and eliminate the need for everyone to have to pay over and over again for the same set of tools," Kalluri said.

About Forte Research Systems

Founded in 2000 and headquartered in Madison, Wisconsin, Forte Research Systems, Inc. develops clinical and translational research management software. The company's flagship product, the OnCore® system, is the nation's most widely adopted clinical research platform among academic research organizations and cancer centers. The OnCore platform is the result of over a decade of experience working closely with large research organizations, including institutes funded by the National Institute of Health's Clinical and Translational Science Award (CTSA) program and forty percent of the NCI designated cancer centers. The company's newest offering, the cloud-based Allegro™ product line is built for clinical research operations excellence with no software to install and no systems administration required.

For information about the OnCore clinical research informatics platform, contact Forte Research Systems at (608) 826-6002 or visit the company online at www.ForteResearch.com.


'/>"/>
SOURCE Forte Research Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ForteBio Introduces New Biosensor for Kinetic Analysis and Screening of Mouse IgG Antibodies
2. Endo Pharmaceuticals Launches FORTESTA™ (Testosterone) Gel for Topical Use Class III for Adult Men in the U.S. With Low Testosterone
3. ForteBio Launches New Octet® RED96 System and Dip and Read™ Protein L Biosensor
4. Endo Pharmaceuticals Receives FDA Approval for FORTESTA™ (Testosterone) Gel as a Class III Product for Topical Use for Men with Low Testosterone
5. Forte Research Systems Unveils the Allegro™ Research on Demand Cloud-Based Product Line
6. New FORTEO® and EVISTA® Data to be Presented at Premiere Scientific Meeting for Bone and Mineral Research
7. ForteBio Announces Launch of Protein G Biosensor for Use on Companys Octet® Instruments
8. Endo Pharmaceuticals Completes Next Step in Regulatory Process for FORTESTA™ for Men With Low Testosterone
9. ForteBio Launches New Dip and Read(TM) Residual Protein A Detection Kit; Introduces Sidekick(TM) Offline Biosensor Immobilization Station for All Octet(R) Instruments
10. FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
11. Sanofi Enters Into Research Collaboration with Weill Cornell Medical College to Discover New Treatments for Tuberculosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... JERUSALEM , April 28, 2016 ... ), a clinical-stage pharmaceutical company focused on the development of ... participate in the upcoming PIONEERS 2016 conference, presented by ... 5, 2016 in New York . ... overview at the conference. Presentation Details:   ...
(Date:4/28/2016)... TapImmune,Inc. (TPIV), a clinical-stage immune-oncology company ... and vaccines for the treatment of cancer & metastatic disease, ... Growth Capital Expo to be held on May 3 ... in Las Vegas, Nevada.  The Company presentation will be ... by Dr. John N. Bonfiglio a TapImmune Board ...
(Date:4/27/2016)... 2016 Im ... Zürich gab Strekin AG den Start einer ... Erhaltung des Resthörvermögens von Patienten, denen ein ... umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan Patienten ... während der Operation direkt ins Mittelohr verabreicht. ...
Breaking Medicine Technology:
(Date:4/30/2016)... ... April 30, 2016 , ... ... questioned the use of the HyProCure sinus tarsi implant. ( http://www.cbc.ca/news/canada/ottawa/banned-quebec-dentist-pierre-dupont-working-as-chiropodist-in-ottawa-1.3515494 ) ... is a minimally invasive procedure performed, when indicated, to correct the partial ...
(Date:4/29/2016)... ... ... In an article published April 16th on the New York ... injections, which she underwent in order to feel more at home at this year’s ... article explains that Ms. Mirmelli’s situation is not unique; many plastic surgeons say they’ve ...
(Date:4/29/2016)... ... April 29, 2016 , ... On Tuesday, April 26, ... the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the “Rural ... (R - Cumming), offers a 70% tax credit to individuals and corporations which donate ...
(Date:4/29/2016)... ... , ... Coast Dental Fort Stewart is celebrating its grand opening with an ... Furniture Mall at 112 Vilseck Road in Fort Stewart. There will be refreshments, giveaways, ... have the opportunity to meet general dentists Thomas Richards, DDS, and Josh Faulk, DMD, ...
(Date:4/29/2016)... ... April 29, 2016 , ... World Patent ... Gyrociser, an exercise invention which aids in proper muscle development. , "The Gym ... and Creative Director of World Patent Marketing. "Globalization has threatened the future growth ...
Breaking Medicine News(10 mins):